Variations in NT-proBNP Levels in Pregnant Patients with and without SARS-CoV-2 Infection: Consequences for the Newborns.

Carmen-Ioana MartaMarius CrainaRazvan NituAnca Laura MaghiariSimona-Alina Abu-AwwadLioara BoscuMircea DiaconuCatalin DumitruBogdan SoropLavinia SteleaKatalin Babes

Published in: Biomedicines (2023)

We consider that NT-proBNP testing in pregnant patients, especially those with COVID-19 infection, can be relevant and be used as a predictive marker to be taken into consideration when it comes to management, outcome, and treatment regarding pregnant patients and their newborns.

Keyphrases

pregnant women
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
preterm infants
coronavirus disease
smoking cessation
patient reported